Public Companies
Filament Health To Host Virtual Investor Update
Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical-stage natural psychedelic drug development company, today announced that it will…

Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical-stage natural psychedelic drug development company, today announced that it will host a virtual update for investors and shareholders on Wednesday, October 19, 2022 at 2:00 p.m. Eastern (11:00 a.m. Pacific).
During the event, Chief Executive Officer (CEO) Benjamin Lightburn and Chief Science Officer (CSO) Ryan Moss will discuss Filament’s recent progress including intellectual property developments, a successful financing, an FDA-approved clinical trial in partnership with the University of California San Francisco, and plans for future growth.
The discussion will be followed by a question-and-answer session with the Company’s senior management team.
A recording of the webcast will be available on the investor section of the Company’s website following the event.
About Filament Health
Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. We are paving the way with the first-ever natural psychedelic drug candidates.

-
LSD16 hours ago
Cannabis Coalition Forms To Push Biden On Federal Reform: Will It Work This Time?
-
LSD15 hours ago
Study Shows New Mechanism For How Psychedelics Promote Plasticity
-
Public Companies15 hours ago
Nirvana Moves Forward With MedSmart Acquisition
-
Psilocybin13 hours ago
Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
-
Markets & Investing13 hours ago
Psychedelics in Dubai: Therapeutic Role of Psychedelics Explored at Conference in the Arab Region
-
Psilocybin6 hours ago
Oregon Pioneers New Psilocybin Business Models
-
Markets & Investing4 hours ago
The 7 Most Promising Penny Stocks to Buy in June